RDHL (Redhill Biopharma) Accumulated Depreciation : $0.00 Mil (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Redhill Biopharma Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Redhill Biopharma's quarterly accumulated depreciation increased from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($-1.25 Mil) but then stayed the same from Dec. 2023 ($-1.25 Mil) to Jun. 2024 ($0.00 Mil).

Redhill Biopharma's annual accumulated depreciation increased from Dec. 2021 ($-0.81 Mil) to Dec. 2022 ($-1.08 Mil) and increased from Dec. 2022 ($-1.08 Mil) to Dec. 2023 ($-1.25 Mil).

Redhill Biopharma Accumulated Depreciation Historical Data

The historical data trend for Redhill Biopharma's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Accumulated Depreciation Chart

Redhill Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.44

-0.60

-0.81

-1.08

-1.25

Redhill Biopharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24
Accumulated Depreciation	Get a 7-Day Free Trial															-1.08	-	-	-1.25	-

Redhill Biopharma Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Redhill Biopharma Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Redhill Biopharma's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Redhill Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (NAS:RDHL) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

21 Ha’arba’a Street, Tel Aviv, ISR, 6473921

Website

https://www.redhillbio.com

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.